Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BSGMNASDAQ:ECORNASDAQ:MOVENASDAQ:SLNO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSGMBioSig Technologies$2.18+12.4%$0.80$0.20▼$2.57$52.87M0.02248,920 shs929,685 shsECORelectroCore$4.82+3.7%$7.35$4.50▼$19.49$34.67M0.9287,084 shs345,593 shsMOVEMovano$0.89+11.4%$1.50$0.71▼$8.85$6.24M0.9526,379 shs47,971 shsSLNOSoleno Therapeutics$76.70-0.1%$63.89$36.93▼$80.99$3.87B-2.67736,284 shs684,278 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSGMBioSig Technologies+12.37%+50.34%+275.73%+146.05%+74.40%ECORelectroCore+1.47%-29.01%-13.46%-70.36%-29.53%MOVEMovano+11.45%+2.19%+9.38%-83.41%-86.42%SLNOSoleno Therapeutics-0.09%+0.27%+14.09%+55.26%+70.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSGMBioSig Technologies1.1114 of 5 stars2.50.00.00.02.60.80.6ECORelectroCore2.3427 of 5 stars3.52.00.00.02.12.50.6MOVEMovano2.1576 of 5 stars3.53.00.00.02.00.80.6SLNOSoleno Therapeutics4.6437 of 5 stars4.61.00.04.62.93.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSGMBioSig Technologies 3.00Buy$2.5014.68% UpsideECORelectroCore 3.00Buy$25.50429.05% UpsideMOVEMovano 3.00Buy$30.003,286.00% UpsideSLNOSoleno Therapeutics 3.11Buy$106.7839.21% UpsideCurrent Analyst Ratings BreakdownLatest BSGM, MOVE, SLNO, and ECOR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025SLNOSoleno TherapeuticsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$81.00 ➝ $97.005/8/2025SLNOSoleno TherapeuticsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$102.00 ➝ $105.004/24/2025SLNOSoleno TherapeuticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$93.00 ➝ $145.004/21/2025BSGMBioSig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.75 ➝ $2.504/15/2025SLNOSoleno TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$100.00 ➝ $100.003/31/2025SLNOSoleno TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$70.00 ➝ $100.003/28/2025SLNOSoleno TherapeuticsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $81.003/28/2025SLNOSoleno TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$74.00 ➝ $108.003/27/2025SLNOSoleno TherapeuticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$105.003/27/2025SLNOSoleno TherapeuticsLaidlawSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$75.00 ➝ $105.003/27/2025SLNOSoleno TherapeuticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$67.00 ➝ $123.00(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSGMBioSig Technologies$40K1,321.73N/AN/A($0.33) per share-6.61ECORelectroCore$25.18M1.38N/AN/A$1.24 per share3.89MOVEMovano$1.01M6.15N/AN/A$0.93 per share0.95SLNOSoleno TherapeuticsN/AN/AN/AN/A$5.16 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSGMBioSig Technologies-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%5/19/2025 (Estimated)ECORelectroCore-$18.83M-$1.56N/AN/AN/A-54.40%-154.45%-69.16%N/AMOVEMovano-$29.28M-$4.07N/A∞N/AN/A-345.78%-198.77%5/21/2025 (Estimated)SLNOSoleno Therapeutics-$38.99M-$4.62N/AN/AN/AN/A-61.99%-55.21%N/ALatest BSGM, MOVE, SLNO, and ECOR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025N/ABSGMBioSig Technologies-$0.18N/AN/AN/AN/AN/A5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million5/7/2025Q1 2025SLNOSoleno Therapeutics-$1.14-$0.95+$0.19-$0.95N/AN/A4/9/2025Q4 2024MOVEMovano-$0.97-$0.61+$0.36-$0.61$1.50 million$0.11 million3/5/2025Q4 2024SLNOSoleno Therapeutics-$0.86-$1.27-$0.41-$1.27N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSGMBioSig TechnologiesN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/AMOVEMovanoN/AN/AN/AN/AN/ASLNOSoleno TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSGMBioSig TechnologiesN/A0.500.50ECORelectroCoreN/A2.121.87MOVEMovanoN/A3.312.83SLNOSoleno TherapeuticsN/A17.2617.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSGMBioSig Technologies7.16%ECORelectroCore26.74%MOVEMovano16.64%SLNOSoleno Therapeutics97.42%Insider OwnershipCompanyInsider OwnershipBSGMBioSig Technologies17.03%ECORelectroCore19.70%MOVEMovano13.40%SLNOSoleno Therapeutics12.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSGMBioSig Technologies5024.25 million14.30 millionNo DataECORelectroCore507.19 million5.35 millionNot OptionableMOVEMovano307.04 million5.75 millionNot OptionableSLNOSoleno Therapeutics3050.39 million37.81 millionOptionableBSGM, MOVE, SLNO, and ECOR HeadlinesRecent News About These CompaniesEquities Analysts Issue Forecasts for SLNO FY2025 EarningsMay 13 at 3:11 AM | americanbankingnews.comSLNO FY2025 EPS Estimate Decreased by Cantor FitzgeraldMay 13 at 2:56 AM | marketbeat.comCrestline Management LP Purchases Shares of 12,943 Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 12 at 5:10 AM | marketbeat.comIs Soleno Therapeutics (SLNO) the Best Performing Healthcare Stock to Buy Now?May 11 at 7:39 PM | insidermonkey.comFarallon Capital Management LLC Buys New Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 11 at 7:40 AM | marketbeat.comRobert W. Baird Increases Soleno Therapeutics (NASDAQ:SLNO) Price Target to $105.00May 10 at 9:11 AM | marketbeat.comSoleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025May 9, 2025 | uk.finance.yahoo.comSoleno Therapeutics Inc (SLNO) Q1 2025 Earnings Call Highlights: Navigating Early Success and ...May 8, 2025 | finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week High - What's Next?May 8, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lifted by Tower Research Capital LLC TRCMay 8, 2025 | marketbeat.comSoleno Therapeutics, Inc. (SLNO) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comSoleno Therapeutics shares rise on VYKAT XR launch updateMay 7, 2025 | in.investing.comSoleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial ResultsMay 7, 2025 | globenewswire.comAlyeska Investment Group L.P. Sells 552,024 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 7, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Comerica BankMay 7, 2025 | marketbeat.comSoleno Therapeutics (SLNO) is on the Move, Here's Why the Trend Could be SustainableMay 6, 2025 | zacks.comInvesco Ltd. Lowers Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 6, 2025 | marketbeat.comMariner LLC Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 5, 2025 | marketbeat.comWells Fargo & Company MN Acquires 3,610 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 5, 2025 | marketbeat.comAlly Bridge Group NY LLC Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 4, 2025 | marketbeat.comSoleno Therapeutics (SLNO) Projected to Post Earnings on WednesdayMay 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesCould Palantir’s Latest Partnership Set a Base for a Move Higher?By Chris Markoch | April 23, 2025View Could Palantir’s Latest Partnership Set a Base for a Move Higher?Taiwan Semiconductor Has a New Reason to Rally on Chip CurbsBy Gabriel Osorio-Mazilli | May 9, 2025View Taiwan Semiconductor Has a New Reason to Rally on Chip CurbsThis Volatile Market Is Made For Nickel-and-Diming These NamesBy Gabriel Osorio-Mazilli | April 21, 2025View This Volatile Market Is Made For Nickel-and-Diming These NamesGold Miners Ready for Breakout Amid Record High PricesBy Chris Markoch | April 28, 2025View Gold Miners Ready for Breakout Amid Record High PricesPeloton Moves Toward Profitability, But Can the Turnaround Last?By Jeffrey Neal Johnson | May 2, 2025View Peloton Moves Toward Profitability, But Can the Turnaround Last?BSGM, MOVE, SLNO, and ECOR Company DescriptionsBioSig Technologies NASDAQ:BSGM$2.18 +0.24 (+12.37%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$2.21 +0.03 (+1.38%) As of 04:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.electroCore NASDAQ:ECOR$4.82 +0.17 (+3.66%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$5.00 +0.18 (+3.71%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Movano NASDAQ:MOVE$0.89 +0.09 (+11.45%) Closing price 05/12/2025 03:55 PM EasternExtended Trading$0.89 0.00 (0.00%) As of 05/12/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.Soleno Therapeutics NASDAQ:SLNO$76.70 -0.08 (-0.10%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$76.20 -0.50 (-0.65%) As of 04:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
